369 related articles for article (PubMed ID: 19295150)
1. Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis.
Centonze D; Muzio L; Rossi S; Cavasinni F; De Chiara V; Bergami A; Musella A; D'Amelio M; Cavallucci V; Martorana A; Bergamaschi A; Cencioni MT; Diamantini A; Butti E; Comi G; Bernardi G; Cecconi F; Battistini L; Furlan R; Martino G
J Neurosci; 2009 Mar; 29(11):3442-52. PubMed ID: 19295150
[TBL] [Abstract][Full Text] [Related]
2. miR-142-3p Is a Key Regulator of IL-1β-Dependent Synaptopathy in Neuroinflammation.
Mandolesi G; De Vito F; Musella A; Gentile A; Bullitta S; Fresegna D; Sepman H; Di Sanza C; Haji N; Mori F; Buttari F; Perlas E; Ciotti MT; Hornstein E; Bozzoni I; Presutti C; Centonze D
J Neurosci; 2017 Jan; 37(3):546-561. PubMed ID: 28100738
[TBL] [Abstract][Full Text] [Related]
3. Cognitive deficits in experimental autoimmune encephalomyelitis: neuroinflammation and synaptic degeneration.
Mandolesi G; Grasselli G; Musumeci G; Centonze D
Neurol Sci; 2010 Nov; 31(Suppl 2):S255-9. PubMed ID: 20635112
[TBL] [Abstract][Full Text] [Related]
4. Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis.
Gentile A; Musella A; Bullitta S; Fresegna D; De Vito F; Fantozzi R; Piras E; Gargano F; Borsellino G; Battistini L; Schubart A; Mandolesi G; Centonze D
J Neuroinflammation; 2016 Aug; 13(1):207. PubMed ID: 27566665
[TBL] [Abstract][Full Text] [Related]
5. The link between inflammation, synaptic transmission and neurodegeneration in multiple sclerosis.
Centonze D; Muzio L; Rossi S; Furlan R; Bernardi G; Martino G
Cell Death Differ; 2010 Jul; 17(7):1083-91. PubMed ID: 19927157
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-223 protects neurons from degeneration in experimental autoimmune encephalomyelitis.
Morquette B; Juźwik CA; Drake SS; Charabati M; Zhang Y; Lécuyer MA; Galloway DA; Dumas A; de Faria Junior O; Paradis-Isler N; Bueno M; Rambaldi I; Zandee S; Moore C; Bar-Or A; Vallières L; Prat A; Fournier AE
Brain; 2019 Oct; 142(10):2979-2995. PubMed ID: 31412103
[TBL] [Abstract][Full Text] [Related]
7. Cathepsin C modulates myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
Durose WW; Shimizu T; Li J; Abe M; Sakimura K; Chetsawang B; Tanaka KF; Suzumura A; Tohyama K; Ikenaka K
J Neurochem; 2019 Feb; 148(3):413-425. PubMed ID: 30152001
[TBL] [Abstract][Full Text] [Related]
8. Reduced Microglial Activity and Enhanced Glutamate Transmission in the Basolateral Amygdala in Early CNS Autoimmunity.
Acharjee S; Verbeek M; Gomez CD; Bisht K; Lee B; Benoit L; Sharkey KA; Benediktsson A; Tremblay ME; Pittman QJ
J Neurosci; 2018 Oct; 38(42):9019-9033. PubMed ID: 30185466
[TBL] [Abstract][Full Text] [Related]
9. Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAE.
Ziehn MO; Avedisian AA; Tiwari-Woodruff S; Voskuhl RR
Lab Invest; 2010 May; 90(5):774-86. PubMed ID: 20157291
[TBL] [Abstract][Full Text] [Related]
10. Laquinimod prevents inflammation-induced synaptic alterations occurring in experimental autoimmune encephalomyelitis.
Ruffini F; Rossi S; Bergamaschi A; Brambilla E; Finardi A; Motta C; Studer V; Barbieri F; De Chiara V; Hayardeny L; Comi G; Centonze D; Martino G
Mult Scler; 2013 Jul; 19(8):1084-94. PubMed ID: 23232603
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological blockade of 2-AG degradation ameliorates clinical, neuroinflammatory and synaptic alterations in experimental autoimmune encephalomyelitis.
Guadalupi L; Mandolesi G; Vanni V; Balletta S; Caioli S; Pavlovic A; De Vito F; Fresegna D; Sanna K; Vitiello L; Nencini M; Tartacca A; Mariani F; Rovella V; Schippling S; Ruf I; Collin L; Centonze D; Musella A
Neuropharmacology; 2024 Jul; 252():109940. PubMed ID: 38570068
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-9 protects from microglia- and TNF-mediated synaptotoxicity in experimental multiple sclerosis.
Guadalupi L; Vanni V; Balletta S; Caioli S; De Vito F; Fresegna D; Sanna K; Nencini M; Donninelli G; Volpe E; Mariani F; Battistini L; Stampanoni Bassi M; Gilio L; Bruno A; Dolcetti E; Buttari F; Mandolesi G; Centonze D; Musella A
J Neuroinflammation; 2024 May; 21(1):128. PubMed ID: 38745307
[TBL] [Abstract][Full Text] [Related]
13. Nav1.6 promotes inflammation and neuronal degeneration in a mouse model of multiple sclerosis.
Alrashdi B; Dawod B; Schampel A; Tacke S; Kuerten S; Marshall JS; Côté PD
J Neuroinflammation; 2019 Nov; 16(1):215. PubMed ID: 31722722
[TBL] [Abstract][Full Text] [Related]
14. Time course and distribution of inflammatory and neurodegenerative events suggest structural bases for the pathogenesis of experimental autoimmune encephalomyelitis.
Brown DA; Sawchenko PE
J Comp Neurol; 2007 May; 502(2):236-60. PubMed ID: 17348011
[TBL] [Abstract][Full Text] [Related]
15. Complement C3 mediates early hippocampal neurodegeneration and memory impairment in experimental multiple sclerosis.
Bourel J; Planche V; Dubourdieu N; Oliveira A; Séré A; Ducourneau EG; Tible M; Maitre M; Lesté-Lasserre T; Nadjar A; Desmedt A; Ciofi P; Oliet SH; Panatier A; Tourdias T
Neurobiol Dis; 2021 Dec; 160():105533. PubMed ID: 34673149
[TBL] [Abstract][Full Text] [Related]
16. Transient receptor potential vanilloid 1 channels modulate the synaptic effects of TNF-α and of IL-1β in experimental autoimmune encephalomyelitis.
Musumeci G; Grasselli G; Rossi S; De Chiara V; Musella A; Motta C; Studer V; Bernardi G; Haji N; Sepman H; Fresegna D; Maccarrone M; Mandolesi G; Centonze D
Neurobiol Dis; 2011 Sep; 43(3):669-77. PubMed ID: 21672630
[TBL] [Abstract][Full Text] [Related]
17. Glatiramer acetate protects against inflammatory synaptopathy in experimental autoimmune encephalomyelitis.
Gentile A; Rossi S; Studer V; Motta C; De Chiara V; Musella A; Sepman H; Fresegna D; Musumeci G; Grasselli G; Haji N; Weiss S; Hayardeny L; Mandolesi G; Centonze D
J Neuroimmune Pharmacol; 2013 Jun; 8(3):651-63. PubMed ID: 23370991
[TBL] [Abstract][Full Text] [Related]
18. Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis.
Musella A; Gentile A; Guadalupi L; Rizzo FR; De Vito F; Fresegna D; Bruno A; Dolcetti E; Vanni V; Vitiello L; Bullitta S; Sanna K; Caioli S; Balletta S; Nencini M; Buttari F; Stampanoni Bassi M; Centonze D; Mandolesi G
Cells; 2020 May; 9(5):. PubMed ID: 32455907
[TBL] [Abstract][Full Text] [Related]
19. Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses.
Lee CH; Jeon SJ; Cho KS; Moon E; Sapkota A; Jun HS; Ryu JH; Choi JW
Mol Neurobiol; 2018 Apr; 55(4):3007-3020. PubMed ID: 28456941
[TBL] [Abstract][Full Text] [Related]
20. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
Aharoni R; Vainshtein A; Stock A; Eilam R; From R; Shinder V; Arnon R
J Autoimmun; 2011 Nov; 37(3):228-41. PubMed ID: 21752599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
